Why is it called kisspeptin?

The gene was named KISS1 by the group that identified it, reportedly after Hershey\u2019s Kisses, the confectionery, since the work was done in Hershey, Pennsylvania. The peptide took its name from the gene. It is a piece of laboratory humour rather than a description of anything, and it is worth knowing only because the name invites assumptions that have nothing to do with the biology.

What is KISS1R and is it the same as GPR54?

Yes, they are the same receptor. It was originally designated GPR54 as an orphan G-protein-coupled receptor, meaning one whose natural ligand was unknown, and was renamed KISS1R once kisspeptin was identified as that ligand. Both names remain in use in the literature depending on the paper\u2019s vintage, which is a common source of confusion when searching.

What is kisspeptin studied for in research?

Principally reproductive endocrinology. Kisspeptin signalling is described in the literature as acting upstream of gonadotropin-releasing hormone, which places it at a control point in the regulation of that axis, and it became a significant research target once that relationship was established. Observations depend on the model, concentration and protocol used, and are properties of those systems rather than general effects.

Why use the fragment rather than the full protein?

Practicality. A full-length protein is harder to synthesise, harder to characterise analytically, and more fragile in handling than a ten-residue peptide. Since the decapeptide retains receptor activity, it gives you the pharmacology you want with none of the handling difficulty. This is a common pattern in peptide research: identify the shortest fragment that still works and use that as the tool.

Do you sell kisspeptin-10?

No. We do not stock it and there is no Certificate of Analysis for it in our library. It is covered here because it draws consistent search interest and the naming around it, both the gene and the two receptor designations, is more confusing than it needs to be.

What is kisspeptin-10?

5 min read · Updated October 2026 · MY PEPTIDES Research Team

Key facts

Kisspeptin-10 is a ten-residue fragment taken from the C-terminal end of kisspeptin, a protein encoded by the KISS1 gene. The full-length protein is processed in the body into shorter active fragments, and the final ten residues retain the ability to activate the receptor, which is why the decapeptide is used as a laboratory tool in place of the whole molecule. Its receptor, KISS1R, was formerly known as GPR54, and both names appear in the literature. Kisspeptin signalling is studied in reproductive endocrinology, where it is described as acting upstream of gonadotropin-releasing hormone, making it a point of interest in work on the regulation of that axis. The gene name is a piece of laboratory whimsy rather than a description. It holds no marketing authorisation in the UK. MY PEPTIDES does not stock it. General information for laboratory context only, not medical advice.

The short answer

Kisspeptin-10 is the last ten amino acids of a protein called kisspeptin, and those ten residues are enough to activate the receptor that the full protein acts on. That is why researchers use the fragment: it does the pharmacological job of the whole molecule and is vastly easier to make and handle.

The receptor is KISS1R, which older papers call GPR54. The research context is reproductive endocrinology, where kisspeptin signalling is described as sitting upstream of gonadotropin-releasing hormone.

The name is a joke, and knowing that helps

The gene was named KISS1 by the group that found it, reportedly after Hershey's Kisses, because the work was done in Hershey, Pennsylvania. The peptide inherited the name from the gene.

This is worth stating plainly because the name does active harm to comprehension. It sounds as though it should mean something, and people reasonably assume it describes a function or a mechanism. It describes a chocolate. Once you know that, the name stops being a distraction.

The receptor naming is more genuinely confusing. KISS1R was originally catalogued as GPR54, an orphan G-protein-coupled receptor, which is the designation given to a receptor whose natural ligand has not yet been identified. When kisspeptin was shown to be that ligand, the receptor was renamed. Both designations persist in the literature according to when a paper was written, so a search on one name will miss work using the other.

Why a fragment instead of the protein

The full-length kisspeptin protein is processed in the body into shorter active fragments, which is common for signalling peptides. Researchers established that the C-terminal ten residues retained the ability to activate the receptor, and from that point the decapeptide became the practical tool.

The reasoning is straightforward. A full-length protein is harder to synthesise, considerably harder to characterise analytically, more prone to misfolding, and more fragile in storage and handling. A ten-residue peptide is trivial by comparison on every one of those counts. If the short fragment engages the receptor the same way, there is no reason to work with the protein.

This "shortest active fragment" pattern recurs throughout peptide research, and it is the same logic behind several other compounds documented on this site. It is also the thing to check when comparing a fragment against its parent: the fragment is a tool for studying the receptor, not a replica of everything the parent protein does.

What is studied, and what that does not mean

Kisspeptin signalling is studied in reproductive endocrinology because of its described position upstream of gonadotropin-releasing hormone. A control point in a hormonal axis is inherently interesting: it offers a way to probe the regulation of the whole cascade rather than one output of it.

As with every compound covered in these guides, published observations belong to the model, concentration, exposure and endpoint used in that work. Research into an endocrine control point does not establish any human application, and this guide describes none.

Kisspeptin-10 holds no marketing authorisation in the UK and is not a licensed medicine here. Supplying an unlicensed product for human medicinal use is unlawful under the Human Medicines Regulations 2012 however a listing is worded, and our guide on whether peptides are legal in the UK covers that framework.

Where MY PEPTIDES stands

We do not stock kisspeptin-10. There is no Certificate of Analysis for it in our library and no product page for it on this site, and this guide is not an offer to supply it. What we do supply, and the documentation standard we hold it to, is set out in our guide on certificates of analysis.

The bottom line

Kisspeptin-10 is the C-terminal decapeptide of kisspeptin, retaining activity at the receptor KISS1R, formerly GPR54, and used as a laboratory tool in place of the full protein. It is studied in reproductive endocrinology as a signalling control point. The name comes from confectionery. It is not an approved medicine and we do not supply it.

All compounds referenced on this site are discussed strictly in the context of in-vitro laboratory research. Nothing here is a medicine, a supplement or a therapeutic product, nothing here describes administration to humans or animals, and this guide is general information rather than medical, legal or research advice.

Frequently asked questions

What is kisspeptin-10?: It is the final ten amino acids of kisspeptin, the protein encoded by the KISS1 gene. The full-length protein is processed into shorter fragments in the body, and this C-terminal decapeptide retains the ability to activate the receptor. That makes it a convenient laboratory substitute for the whole protein: far easier to synthesise, far easier to characterise, and sufficient for receptor work.
Why is it called kisspeptin?: The gene was named KISS1 by the group that identified it, reportedly after Hershey\u2019s Kisses, the confectionery, since the work was done in Hershey, Pennsylvania. The peptide took its name from the gene. It is a piece of laboratory humour rather than a description of anything, and it is worth knowing only because the name invites assumptions that have nothing to do with the biology.
What is KISS1R and is it the same as GPR54?: Yes, they are the same receptor. It was originally designated GPR54 as an orphan G-protein-coupled receptor, meaning one whose natural ligand was unknown, and was renamed KISS1R once kisspeptin was identified as that ligand. Both names remain in use in the literature depending on the paper\u2019s vintage, which is a common source of confusion when searching.
What is kisspeptin studied for in research?: Principally reproductive endocrinology. Kisspeptin signalling is described in the literature as acting upstream of gonadotropin-releasing hormone, which places it at a control point in the regulation of that axis, and it became a significant research target once that relationship was established. Observations depend on the model, concentration and protocol used, and are properties of those systems rather than general effects.
Why use the fragment rather than the full protein?: Practicality. A full-length protein is harder to synthesise, harder to characterise analytically, and more fragile in handling than a ten-residue peptide. Since the decapeptide retains receptor activity, it gives you the pharmacology you want with none of the handling difficulty. This is a common pattern in peptide research: identify the shortest fragment that still works and use that as the tool.
Do you sell kisspeptin-10?: No. We do not stock it and there is no Certificate of Analysis for it in our library. It is covered here because it draws consistent search interest and the naming around it, both the gene and the two receptor designations, is more confusing than it needs to be.